US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 40.600
  • -0.890-2.15%
Close Dec 23 16:00 ET
  • 40.600
  • 0.0000.00%
Post 16:00 ET
2.42BMarket Cap14.82P/E (TTM)

About Protagonist Therapeutics Company

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Company Profile

SymbolPTGX
Company NameProtagonist Therapeutics
Listing DateAug 11, 2016
Issue Price12.00
Founded2006
CEODr. Dinesh V. Patel, PhD
MarketNASDAQ
Employees112
Fiscal Year Ends12-31
Address7707 Gateway Boulevard,Suite 140
CityNewark
ProvinceCalifornia
CountryUnited States of America
Zip Code94560-1160
Phone1-510-474-0170
Websitehttp://www.protagonist-inc.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Dinesh V. Patel, PhD
  • Director, President and Chief Executive Officer
  • 7.07M
  • Dr. Arturo Molina, M.D.
  • Chief Medical Officer
  • --
  • Dr. Suneel Gupta, PhD
  • Chief Development Officer
  • 2.22M
  • Asif Ali
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 1.40M
  • Dr. Harold E. Selick, PhD
  • Chairman of the Board
  • 395.27K
  • Bryan Giraudo
  • Independent Director
  • 356.52K
  • Dr. Lewis T. Willia M.D.,PhD
  • Independent Director
  • 351.52K
  • William D. Waddill
  • Independent Director
  • 364.02K
  • Sarah A. O’Dowd
  • Independent Director
  • 341.52K
Heat List
US
Overall
Symbol
Price
% Chg

No Data